BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study - Concepedia

Concepedia

Publication | Open Access

BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study

DOI Full Paper Access

57

Citations

31

References

2022

Year

Amber Louw, Vasiliki Panou, Weronika Maria Szejniuk, Christos Meristoudis, Siaw Ming Chai, Claire van Vliet, Gary Lee, Ian M. Dick, Tina Firth, Louise Andersen Lynggaard,

Journal of Thoracic Oncology

References

	Year	Citations

Page 1